Prolieve Thermodilatation^® System

The Prolieve® System is the next generation in minimally invasive therapy for the symptoms of BPH.

This dual-action thermodilatation technology simultaneously heats the prostate while dilating the prostatic urethra. The treatment is well tolerated by patients and most patients do not require post-treatment catheterization.

HEALTH CARE PROFESSIONALS

Overview

Prescriptive Information

Print Materials

PATIENTS

Product Information

The Prolieve Thermodilatation System consists of the Prolieve System Console, a Transurethral Microwave Catheter, a Rectal Temperature Monitor and a Heat Exchange Cartridge.

The Prolieve System catheter uses microwave heating to reduce the enlarged prostate tissue and improve urine flow. In addition to microwave heating, the catheter includes a compression balloon that expands and compresses prostatic tissue.

The Temperature Monitor measures the rectal wall temperature at three points.

Dual-action thermodilatation technology heats and dilates the prostatic urethra
Computer-controlled transurethral microwave heat is delivered directly to the prostate
Circulated water flows through the thermodilitation balloon in the urethra
A single-visit outpatient procedure
Procedure is performed in a physician's office
There is no anesthesia required
The procedure is minimally invasive in men for whom drug therapy is typically indicated
Eighty-two percent (82%) of patients do not require post-treatment catheterization. (Results based on pivotal clinical trial, 140 patients treated.)